However, somatic LRRK2 mutations in breast cancer are associated with high-risk features and reduced patient survival29, consistent with a potential risk for lung adenocarcinoma with reduced LRRK2 levels30, emphasizing the concern of targeting LRRK2 in humans. The gene discussed is LRRK2; the disease is breast cancer.